Results 101 to 110 of about 397,934 (398)
ESC Heart Failure, EarlyView.Abstract Aims Guideline‐directed medical therapy (GDMT) is recommended for all patients with heart failure with reduced ejection fraction (HFrEF). Despite this, little data exist describing GDMT use in diverse, real‐world populations including the use of vasodilators, prescribed primarily to Black populations.
Natalia C. Berry +4 more
wiley +1 more source
Annals of Noninvasive Electrocardiology, Volume 28, Issue 1, January 2023., 2023 Accurate automatic wide QRS complex tachycardia (WCT) differentiation may be accomplished through the use of novel parameters derived from computerized data of the (i) WCT electrocardiogram (ECG) alone and (ii) paired WCT and baseline ECGs. Once automated WCT differentiation models are integrated into commercially available computerized ECG ...
Anthony H. Kashou +16 more
wiley +1 more source
Рациональная фармакотерапия в кардиологии, 2019 The article is devoted to the description of all types of atrial tachyarrhythmias, including inappropriate sinus tachycardia, which, as a rule, is not paid enough attention in the domestic literature, sinoatrial node reentrant tachycardia, focal and ...
Yu. A. Bunin +3 more
doaj +1 more source
ESC Heart Failure, 2022 Aims Atrial fibrillation (AF)/atrial flutter is common during cardiac amyloidosis (CA). Electrical cardioversion (EC) is a strategy to restore sinus rhythm (SR). However, left atrial thrombus (LAT) represents a contraindication for EC.
Olivier Touboul +13 more
doaj +1 more source
An Approach to Catheter Ablation of Cavotricuspid Isthmus Dependent Atrial Flutter [PDF]
, 2006 Much of our understanding of the mechanisms of macro re-entrant atrial tachycardia comes from study of cavotricuspid isthmus (CTI) dependent atrial flutter.
Clémenty, Jacques +10 more
core +2 more sources
ESC Heart Failure, EarlyView.Abstract Aims This study aimed to investigate potential biomarkers for predicting incident heart failure (HF) in patients with atrial fibrillation and flutter (AF and AFL), utilizing proteomic data from the UK Biobank Pharma Proteomics Project (UKB‐PPP).
Gaifeng Hu +8 more
wiley +1 more source
Annals of Noninvasive Electrocardiology, Volume 28, Issue 1, January 2023., 2023 Confirm‐AF is a prospective randomized, nonblinded, two arm, multicenter clinical trial, which will enroll 477 patients with a history of HF hospitalization and left ventricular ejection fraction >35% from 30 medical sites. Patients will be randomized in a 2:1 fashion to receive an implantable cardiac monitor (ICM) with remote monitoring and symptom ...
Mehmet K. Aktas +12 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Tricuspid regurgitation (TR) results in right atrial remodelling, thus promoting the formation of a substrate for atrial fibrillation (AF). In turn, AF may cause TR by annulus dilatation. We investigated whether the presence of TR affects the efficacy of pulmonary vein isolation (PVI) for AF. Methods and results In patients undergoing PVI,
Jan Wintrich +7 more
wiley +1 more source
RUDN Journal of Medicine, 2016 Aim - to evaluate the effectiveness of radiofrequency ablation cavotricuspid of the isthmus in patients with diabetes mellitus (DM) type 2, and typical atrial flutter, as well as to identify the factors of recurrence of atrial flutter after the procedure.
Yu A Kachanova, N A Novikova, A L Syrkin
doaj
Journal of Arrhythmia, 2021 Background Although less common, typical atrial flutter shares similar pathophysiological roots with atrial fibrillation. Following successful cavo‐tricuspid isthmus ablation using radiofrequency, many patients, however, develop atrial fibrillation in ...
Frédéric Anselme +14 more
doaj +1 more source